| 701288 |
FRONTIERS IN ONCOLOGY |
The Inflammatory Profile of the Tumor Microenvironment, Orchestrated by Cyclooxygenase-2, Promotes Epithelial-Mesenchymal Transition |
2021-06-10 |
10.3389/fonc.2021.686792 |
Gómez-Valenzuela Fernán, Escobar Enrico, Pérez-Tomás Ricardo, Montecinos Viviana P. |
| 701287 |
FRONTIERS IN ONCOLOGY |
Tumor-Associated Macrophages: A Potential Target for Cancer Therapy |
2021-06-10 |
10.3389/fonc.2021.693517 |
Tan Yifan, Wang Min, Zhang Yang, Ge Shengyang, Zhong Fan, Xia Guowei, Sun Chuanyu |
| 701286 |
FRONTIERS IN ONCOLOGY |
Survival in Patients With Metastatic Prostate Cancer Undergoing Radiotherapy: The Importance of Prostate-Specific Antigen-Based Stratification |
2021-06-10 |
10.3389/fonc.2021.706236 |
Tian Zijian, Meng Lingfeng, Wang Xin, Wang Xuan, Ma Tianming, Wang Miao, Zhong Qiuzi, Zhang Yaqun, Liu Ming |
| 701285 |
FRONTIERS IN ONCOLOGY |
The Anti-Non-Small Cell Lung Cancer Cell Activity by a mTOR Kinase Inhibitor PQR620 |
2021-06-10 |
10.3389/fonc.2021.669518 |
Zha Jian-hua, Xia Ying-chen, Ye Chun-lin, Hu Zhi, Zhang Qin, Xiao Han, Yu Ben-tong, Xu Wei-hua, Xu Guo-qiu |
| 701284 |
FRONTIERS IN ONCOLOGY |
Real-World Data on Apatinib Efficacy - Results of a Retrospective Study in Metastatic Breast Cancer Patients Pretreated With Multiline Treatment |
2021-06-10 |
10.3389/fonc.2021.643654 |
Liu Zhaoyun, Shan Jing, Yu Qian, Wang Xinzhao, Song Xiang, Wang Fukai, Li Chao, Yu Zhiyong, Yu Jinming |
| 701283 |
FRONTIERS IN ONCOLOGY |
Partial Nephrectomy Versus Radical Nephrectomy for Clinical T2 or Higher Stage Renal Tumors: A Systematic Review and Meta-Analysis |
2021-06-10 |
10.3389/fonc.2021.680842 |
Huang Ruizhen, Zhang Chiyu, Wang Xing, Hu Honglin |
| 701282 |
FRONTIERS IN ONCOLOGY |
N6-Methyladenosine Associated Silencing of miR-193b Promotes Cervical Cancer Aggressiveness by Targeting CCND1 |
2021-06-10 |
10.3389/fonc.2021.666597 |
Huang Chunxian, Liang Jinxiao, Lin Shaodan, Wang Dongyan, Xie Qingsheng, Lin Zhongqiu, Yao Tingting |
| 701281 |
FRONTIERS IN ONCOLOGY |
Durable Response to the Combination of Atezolizumab With Platinum-Based Chemotherapy in an Untreated Non-Smoking Lung Adenocarcinoma Patient With BRAF V600E Mutation: A Case Report |
2021-06-10 |
10.3389/fonc.2021.634920 |
Niu Xiaomin, Sun Yingjia, Planchard David, Chiu Luting, Bai Jian, Ai Xinghao, Lu Shun |
| 701280 |
FRONTIERS IN ONCOLOGY |
MAPK-RAP1A Signaling Enriched in Hepatocellular Carcinoma Is Associated With Favorable Tumor-Infiltrating Immune Cells and Clinical Prognosis |
2021-06-10 |
10.3389/fonc.2021.649980 |
Li Hailin, Han Guangyu, Li Xing, Li Bowen, Wu Bo, Jin Hongyuan, Wu Lingli, Wang Wei |
| 701279 |
FRONTIERS IN ONCOLOGY |
Implemented Interventions at the Naef K. Basile Cancer Institute to Protect Patients and Medical Personnel From COVID Infections: Effectiveness and Patient Satisfaction |
2021-06-10 |
10.3389/fonc.2021.685107 |
El Cheikh Jean, El Warrak Samantha, Ghaoui Nohra, Al Chami Farouk, Shahbaz Maya, Chehayeb Sarah, Saghir Nagi, Bazarbachi Ali, Taher Ali |
